Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Michael Maker"'
Autor:
Hiroyuki Yokota, Joseph Krueger, Apollina Goel, Michael Ross, Jeanette Rheinhardt, Peter Duval, Michael Maker, Kenneth Bloom, George Abe, Ann Ranger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/4cc09423f87641c49ba247e561dcdc60
Autor:
Joy G. Ghosh, Andrew A. Nguyen, Chad E. Bigelow, Stephen Poor, Yubin Qiu, Nalini Rangaswamy, Richard Ornberg, Brittany Jackson, Howard Mak, Tucker Ezell, Vania Kenanova, Elisa de la Cruz, Ana Carrion, Bijan Etemad-Gilbertson, Roxana Garcia Caro, Kan Zhu, Vinney George, Jirong Bai, Radhika Sharma-Nahar, Siyuan Shen, Yiqin Wang, Kulandayan K. Subramanian, Elizabeth Fassbender, Michael Maker, Shawn Hanks, Joanna Vrouvlianis, Barrett Leehy, Debby Long, Melissa Prentiss, Viral Kansara, Bruce Jaffee, Thaddeus P. Dryja, Michael Roguska
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Retinal vascular disease treatments involve frequent pharmacological intraocular administrations. Here the authors present a method to increase the half-life of injected drugs by fusing these to a hyaluronan-binding peptide, which might lead to less
Externí odkaz:
https://doaj.org/article/f0adf43d440f4267b734d5d4506d7186
Autor:
Vivian W Choi, Chad E Bigelow, Terri L McGee, Akshata N Gujar, Hui Li, Shawn M Hanks, Joanna Vrouvlianis, Michael Maker, Barrett Leehy, Yiqin Zhang, Jorge Aranda, George Bounoutas, John T Demirs, Junzheng Yang, Richard Ornberg, Yu Wang, Wendy Martin, Kelly R Stout, Gregory Argentieri, Paul Grosenstein, Danielle Diaz, Oliver Turner, Bruce D Jaffee, Seshidhar R Police, Thaddeus P Dryja
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss , Pp - (2015)
Recessive mutations in RLBP1 cause a form of retinitis pigmentosa in which the retina, before its degeneration leads to blindness, abnormally slowly recovers sensitivity after exposure to light. To develop a potential gene therapy for this condition,
Externí odkaz:
https://doaj.org/article/543b664ff66b42138de04c51579aee00
Autor:
Stefania Chetcuti Zammit, Mark E. McAlindon, Elliot Greenblatt, Michael Maker, Jenifer Siegelman, Daniel A. Leffler, Ozlem Yardibi, David Raunig, Terry Brown, Reena Sidhu
Publikováno v:
Current Medical Imaging Formerly Current Medical Imaging Reviews. 19
Background: Video capsule endoscopy (VCE) is an attractive method for diagnosing and objectively monitoring disease activity in celiac disease (CeD). Its use, facilitated by artificial intelligence-based tools, may allow computer-assisted interpretat
Autor:
Michael Ross, Apollina Goel, George Abe, Joseph S. Krueger, Michael Maker, Jeanette Rheinhardt, Hiroyuki Yokota, Kenneth Bloom, Ann Ranger, Peter Duval
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background CD20, a membrane B cell marker, is expressed on the majority of mature B cell neoplasms, including diffuse large B cell lymphoma and follicular lymphoma. Importantly, CD20 is the target of rituximab as well as autologous T cell and BiTE®
Autor:
Stephen Poor, Namrata Kotagiri, Yubin Qiu, Siyuan Shen, Elizabeth Fassbender, Adrian Will-Orrego, Bruce D Jaffee, Jorge Aranda, Sha-Mei Liao, Michael Maker
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 34:489-499
Mononuclear phagocytes (MNPs) are present in neovascular age-related macular degeneration (nv AMD) which is also called choroidal neovascularization (CNV). The number and phenotype of the MNPs depend upon the local environment in the CNV and effect o
Autor:
Ana Carrion, Debby Long, Andrew Anh Nguyen, Michael Roguska, Elisa de la Cruz, Bruce D Jaffee, Stephen Poor, Kulandayan K. Subramanian, Bijan Etemad-Gilbertson, Vania Kenanova, Shawn Hanks, Roxana Garcia Caro, Nalini Rangaswamy, Kan Zhu, Barrett Leehy, Elizabeth Fassbender, Chad E Bigelow, Howard H. Mak, Joy Ghosh, Jirong Bai, Yubin Qiu, Viral Kansara, Radhika Sharma-Nahar, Siyuan Shen, Michael Maker, Melissa Prentiss, Brittany Jackson, Richard Ornberg, Joanna Vrouvlianis, Vinney George, Yiqin Wang, Tucker Ezell, Thaddeus P. Dryja
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Nature Communications
Nature Communications
Protein drugs that neutralize vascular endothelial growth factor (VEGF), such as aflibercept or ranibizumab, rescue vision in patients with retinal vascular diseases. Nonetheless, optimal visual outcomes require intraocular injections as frequently a
Autor:
Joy Ghosh, Kellyann Kovach, Sudeep Chandra, Michael Maker, Jan Penraat, Guillaume Normand, Cynthia L. Grosskreutz
Publikováno v:
Communications Biology
Communications Biology, Vol 3, Iss 1, Pp 1-11 (2020)
Communications Biology, Vol 3, Iss 1, Pp 1-11 (2020)
Intravitreal (IVT) injection has become the standard route for drug administration in retinal diseases. However, the ability to measure biodistribution of ocular therapeutics in large species remains limited, due to the invasive nature of some techni
Autor:
Terry Brown, Michael Maker, Reena Sidhu, Kevin Galinsky, Suzanne K. Lewis, Ozlem N. Yardibi, Luca Elli, Elliot Greenblatt, Daniel A. Leffler, Jenifer Siegelman
Publikováno v:
Gastroenterology. 158:S-156